Screening for esophageal disease with unsedated transnasal endoscopy is safe and feasibleMay 10, 2012
OAK BROOK, Ill. - May 10, 2012 - Researchers report that unsedated transnasal endoscopy is a feasible, safe, and well-tolerated method to screen for esophageal disease in a primary care population. This study is the largest reported experience with transnasal endoscopy in the United States. The study appears in the May issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).
Esophageal cancer is the most rapidly increasing type of neoplasia in terms of incidence in the United States over the last three decades. Endoscopic screening for esophageal neoplasia can identify patients who might benefit from early intervention for precancerous lesions. Unsedated transnasal endoscopy, also called transnasal esophagoscopy (TNE), may provide an efficient and accurate endoscopic assessment for esophageal neoplasia with fewer risks and less cost as compared with conventional upper endoscopy. Standard upper endoscopy allows for the identification of precancerous lesions or cancer of the esophagus, and is commonly performed with conscious sedation and occasionally with the patient under general anesthesia.
TNE uses ultrathin endoscopes that are passed through the patient's nose into the esophagus for performance of an upper endoscopy; typically the examination is carried out at least to the level of the proximal-to-mid stomach, depending on the height of the patient. Often, TNE can be performed without sedation through the use of topical anesthetics sprayed into the patient's nose and/or mouth. Avoiding intravenous sedation allows patients to drive following the examination and eliminates the need for a second person to accompany the patient to the examination. TNE procedures do not always result in complete upper endoscopy examinations, because a patient who is not sedated may not tolerate passage of the endoscope through the entire stomach, the duodenal bulb, and the second portion of the duodenum.
"Unsedated small-caliber TNE offers the possibility of efficient and accurate endoscopic assessment of the esophagus with less cost and fewer risks compared with sedated upper endoscopy. The sensitivity of detecting esophageal abnormalities with unsedated small-caliber TNE is comparable to that of conventional upper endoscopy," said study lead author Blair A. Jobe, MD, University of Pittsburgh Medical Center, Pittsburgh, Penn. "Studies in North America have been limited by small sample sizes and have been performed in populations selected for esophageal symptoms. These highly selected populations in referral settings have limited our ability to adequately risk stratify esophageal adenocarcinoma to achieve early detection and cure. Our study demonstrates that unsedated transnasal endoscopy is both feasible and safe in a primary care population, achieving short procedure times, a high diagnostic yield, and minimal anxiety. Patients reported good acceptability and minimal discomfort. These results suggest that we can now lower the threshold for endoscopic esophageal screening and with less cost."
The study assessed the feasibility, safety, acceptability, and yield of unsedated TNE in a primary care population. It was a multicenter, prospective, cross-sectional study conducted between 2009 and 2010 at two outpatient tertiary-care centers with a general medical clinic population aged between 40 and 85 years. The main outcome measurements included procedure yield; completeness of examination; procedure length; adverse events and complications; choking, gagging, pain, or anxiety during the examination; and overall tolerability.
A total of 426 participants enrolled in the study, and 422 (99 percent) completed the examination. Mean examination time was 3.7 minutes. There were no serious adverse events, and 12 participants (2.8 percent) reported minor complications. Participants reported minimal choking, gagging, pain, or anxiety. The examination was well-tolerated by most participants. Overall, 38 percent of participants had an esophageal finding that changed management (34 percent erosive esophagitis, 4 percent Barrett's esophagus). The majority of participants (70 percent) reported reflux or heartburn symptoms. Almost a third (29 percent) reported excess mucus in the nose or throat, and a quarter reported (25 percent) hoarseness. Approximately a fifth of participants reported globus (20 percent), chronic throat clearing (20 percent), chest pain (19 percent), or dysphagia (18 percent). Thirteen percent reported chronic sinusitis, 7 percent chronic sore throat, and 5 percent odynophagia.
The researchers noted that because two endoscopists with extensive experience in TNE performed the examinations, it is possible that patient tolerability would be lower with less experienced endoscopists. The study's authors concluded that unsedated TNE is a feasible, safe, and well-tolerated method to screen for esophageal disease in a primary care population and endoscopic findings are common in this patient population.
In an accompanying editorial, Douglas G. Adler, MD, FASGE, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, states, "Who should undergo TNE without sedation? Ideally, TNE should be considered in asymptomatic patients desiring screening for Barrett's esophagus based on family history or other factors. TNE might also be appropriate for patients with symptoms strongly suggestive of esophageal pathology in whom standard endoscopy is problematic or unappealing or in whom a complete upper endoscopy is not warranted. It will be interesting to see if the coming years see TNE without sedation enter mainstream practice and widespread use. Many factors are in play, ranging from the technical to financial, and the use of these devices in the outpatient clinic situation, although appealing, is not without limitations. Ultrathin endoscopes may be technical marvels, but their ideal role in day-to-day practice remains undetermined."
Since its founding in 1941, the American Society for Gastrointestinal Endoscopy (ASGE) has been dedicated to advancing patient care and digestive health by promoting excellence and innovation in gastrointestinal endoscopy. ASGE, with more than 12,000 members worldwide, promotes the highest standards for endoscopic training and practice, fosters endoscopic research, recognizes distinguished contributions to endoscopy, and is the foremost resource for endoscopic education. Visit www.asge.org and www.screen4coloncancer.org for more information and to find a qualified doctor in your area.
Endoscopy is performed by specially-trained physicians called endoscopists using the most current technology to diagnose and treat diseases of the gastrointestinal tract. Using flexible, thin tubes called endoscopes, endoscopists are able to access the human digestive tract without incisions via natural orifices. Endoscopes are designed with high-intensity lighting and fitted with precision devices that allow viewing and treatment of the gastrointestinal system.
American Society for Gastrointestinal Endoscopy
Related Esophagus Articles:
Oxford University Press and the International Society for Diseases of the Esophagus (ISDE) are pleased to announce their new partnership to publish Diseases of the Esophagus, ISDE's monthly scientific journal.
New ways of using mechanisms behind certain blood pressure medications may in the future spare some patient groups both discomfort and lifelong concern over cancer of the esophagus.
Recognizing early stages of esophageal cancer is difficult because it can easily be missed.
Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced.
The 'acid' in 'acid reflux' may not be the direct cause of damage to the esophagus as previously suspected, according to researchers at UT Southwestern Medical Center and Dallas VA Medical Center.
Dr. William Grady, a clinical researcher and cancer geneticist at Fred Hutch, has been awarded a $180,000 grant from the DeGregorio Family Foundation for Gastric and Esophageal Cancer Research and the Price Family Foundation for a two-year project to develop a better way to identify people at highest risk for esophageal adenocarcinoma, the most common cancer of the esophagus.
Scientists from Brazilian institutions and the Yale University School of Medicine have elucidated the chemical process behind a mysterious gastrointestinal disease that is becoming more frequent every day: the eosinophilic esophagitis (EoE), also known as the 'asthma of the esophagus'.
New research from the University of Warwick and University Hospitals Coventry and Warwickshire NHS Trust could transform treatments and diagnosis for a common digestive condition which affects thousands of patients.
A new minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression can be used to identify patients with reflux symptoms who warrant endoscopy to diagnose Barrett's esophagus, according to a study published by Rebecca Fitzgerald and colleagues from the MRC Cancer Unit, UK, in this week's PLOS Medicine.
In a first step toward future human therapies, researchers at The Saban Research Institute of Children's Hospital Los Angeles have shown that esophageal tissue can be grown in vivo from both human and mouse cells.
Related Esophagus Reading:
The Esophagus: Medical and Surgical Management, 1e
by Lucius Hill MD FACS (Author), Richard A. Kozarek MD FASGE (Author), Richard McCallum MD FACP FACG (Author), Dale C. Mercer MD FRCS (Author)
Integrates gastroenterology and thoracic surgery to detail the comprehensive management of esophageal disease. Describes radiologic and functional evaluation of the esophagus, endoscopy, medical and surgical treatments, and results. Covers gastroesophageal reflux disease, tumor motility, esophageal replacement, intubation, esophageal diverticula, caustic esophageal injury, and more. Presents Dr. Hill's renowned surgical procedures in detail! View Details
Esophagus, Stomach, Duodenum (Atlas of Operative Surgery Special Anatomy, Inidcations, Techniques, Complications Vol 3)
by W. Lierse,W. Platzer,Karl (EDT) Kremer,W. (EDT) Lierse K. Kremer (Author)
Book by View Details
How I Cured My Barrett's Esophagus
If your doctor told you that there was no cure for Barrett's esophagus don't believe it... That's what my doctor told me too... But after extensive research and using myself as a guinea pig I finally decided to go to a Naturopathic doctor. That's when things really started to turn around for me. Within months I started to feel better and in just 7 months I was able to completely heal my Barrett's esophagus which is verified in my book via pathology reports. Several people who have followed my protocol have reversed their Barrett's too... What have you got to lose but Barrett's download the... View Details
The SAGES Manual of Strategic Decision Making: Case Studies in Minimal Access Surgery
by Carol E.H. Scott-Conner (Editor), José E. Torres (Editor), Nate Thepjatri (Editor)
Fifty scenarios in general surgery are described and possible treatment options are considered. A case presentation format is used to illustrate the author’s preferred strategy, supported by evidence from the literature. Alternate approaches favored by other experts are also presented. An excellent clinical decision making tool for general surgeons and residents.View Details
Surgery of the Esophagus and Stomach: Handbooks in General Surgery (2010-10-13)
by Springer; 2011 edition (2010-10-13) (Publisher)
Barrett's Esophagus and Cancer, An Issue of Surgical Oncology Clinics, 1e (The Clinics: Surgery)
by Prateek Sharma MD (Author)
Cellular mechanisms of BE development; Role of obesity and familial factors in BE and cancer; Histology of metaplasia and dysplasia; Molecular markers and genetics in cancer development; Improving screening practices for BE; Risk factors for BE cancer development; New technologies for BE imaging; Medical treatment and cancer prevention; Endoscopic therapy in BE; Surgical therapy for high grade dysplasia and early cancer; Role of neoadjuvant therapy for BE cancer; Surgical palliation for BE cancer View Details
Chassin's Operative Strategy in Esophageal Surgery
by Carol E.H. Scott-Conner (Editor), C. Henselmann (Editor)
True Atlas, brilliantly illustrated.
Succint review of surgical techniques, including minimally invasive approaches for GERD.
Step by Step descriptions of 13 operative procedures in esophageal surgery.
Significantly lower priced than it's competitors.
Educed from Chassin's Operative Strategies in General Surgery, bound to be a classic.
Minimally Invasive Foregut Surgery for Malignancy: Principles and Practice
by Steven N. Hochwald (Editor), Moshim Kukar (Editor)
This book provides detailed, comprehensive and illustrative content to the surgical community in the areas of foregut oncologic surgery. The text contains an in depth review of all surgical aspects of oncologic diseases involving the stomach and esophagus. The main focus is on the minimally invasive techniques including potential complications and their management. The text also includes an online link for the videos for all minimally invasive foregut surgical procedures including animation content which provide a more comprehensive learning experience. ... View Details
Surgery of the Alimentary Tract, Vol. 1: Esophagus, Stomach & Duodenum, Liver, Gallbaldder and Extrahepatic Biliary Ducts
by Richard T. Shackelford (Author), Hammond J. Dugan (Author)
Johns Hopkins Patients' Guide to Cancer of the Stomach and Esophagus
by Mark D. Duncan (Author)
Johns Hopkins Patients' Guide to Cancer of the Stomach and Esophagus is a concise, easy-to-follow "how to" guide that puts you on a path to wellness by explaining stomach and liver cancer treatment from start to finish. It guides you through the overwhelming maze of treatment decisions, simplifies the complicated schedule that lies ahead, and performs the task of putting together your plan of care in everyday terms. Empower yourself with accurate, understandable information that will give you the ability to confidently participate in the decision making about your care and treatment. View Details